GGrantIndex
Sort

25,944 grants matching neurodegeneration

Immune-based nutrient deprivation and neurodegenerative disease

$506,234
Carol A Colton · Duke University · R01 · FY2013 · AG

Targeting Autonomic Flexibility to Enhance Cognitive Training Outcomes in Older Adults with Mild Cognitive Impairment

$506,138
Kathi L Heffner · University Of Rochester · R01 · FY2023 · NR

Role of MyD88 signaling in systemic inflammation and Alzheimer disease

$506,127
Ken-Ichiro Fukuchi · University Of Illinois At Chicago · R01 · FY2024 · AG

In vitro myelination assay modeling the environment of MS lesions for predictive discovery of remyelinating therapies.

$506,083
Anna Jagielska · Artificial Axon Labs Inc. · R43 · FY2024 · NS

Longevity assurance interventions, metabolic health and Alzheimer's Disease

$506,080
Liou Sun · University Of Alabama At Birmingham · R01 · FY2019 · AG

Mechanistic Investigation of Neuropathological Interactions between COVID-19 and Progression of Lewy Pathology and Dementia

$506,052
Xiaohong Lu · Louisiana State Univ Hsc Shreveport · R56 · FY2024 · NS

Mechanisms of synaptic dysfunction in Parkinson's and other synuclein-linked diseases

$505,993
Jennifer R Morgan · Marine Biological Laboratory · R01 · FY2018 · NS

Murine Transgenic Models of Prion Diseases

$505,981
David A Harris · Boston University Medical Campus · R01 · FY2011 · NS

Nano-Pulsed Optoacoustic Neuromodulation for Reducing Traumatic Brain Injury-Driven Neuropathology and Improving Cognitive Outcome

$505,771
Maria-Adelaide Micci · University Of Texas Med Br Galveston · R01 · FY2025 · NS

Nano-Pulsed Optoacoustic Neuromodulation for Reducing Traumatic Brain Injury-Driven Neuropathology and Improving Cognitive Outcome

$505,771
Maria-Adelaide Micci · University Of Texas Med Br Galveston · R01 · FY2023 · NS

Nano-Pulsed Optoacoustic Neuromodulation for Reducing Traumatic Brain Injury-Driven Neuropathology and Improving Cognitive Outcome

$505,771
Maria-Adelaide Micci · University Of Texas Med Br Galveston · R01 · FY2022 · NS

SSH1-Nrf2 nexus in tipping the balance between degeneration and protection in tauopathies.

$505,696
David E Kang · Case Western Reserve University · R01 · FY2023 · AG

Spinocerebellar Ataxia Type 2 Gene and Gene Product

$505,585
Stefan M. Pulst · University Of Utah · R37 · FY2014 · NS

Novel biological insights by utilizing mitochondrial genome information from HuBMAP resources

$505,417
Liming Pei · Children'S Hosp Of Philadelphia · U01 · FY2024 · HL

Determining the role of CLN3 in the eye

$505,390
Ruchira Singh · University Of Rochester · R01 · FY2020 · EY

Linking metabolism, neural function, and aging

$505,246
Kaveh Ashrafi · University Of California, San Francisco · R01 · FY2023 · AG

Linking metabolism, neural function, and aging

$505,246
Kaveh Ashrafi · University Of California, San Francisco · R01 · FY2021 · AG

Linking metabolism, neural function, and aging

$505,246
Kaveh Ashrafi · University Of California, San Francisco · R01 · FY2022 · AG

PARKINSON'S DISEASES SUSCEPTIBILITY GENES AND PESTICIDES

$505,207
University Of California Los Angeles · R01 · FY2002 · ES

HTS to identify small molecules to disrupt abnormal huntingtin interactions in HD

$505,200
Nancy A Muma · University Of Kansas Lawrence · R01 · FY2015 · NS

Characterizing the Conformations and Neurotoxic Species of Huntingtin

$505,154
Ali Khoshnan · California Institute Of Technology · R01 · FY2022 · NS

Mindfulness to Enhance Cognitive Health in Latinx Older Adults at Risk for Alzheimer's Disease

$505,115
Todd Braver · Washington University · R61 · FY2024 · AG

Modulating Energy Metabolism as a Therapeutic Approach for Alzheimer's Disease

$505,100
M Flint Beal · Winifred Masterson Burke Med Res Inst · P01 · FY2020 · AG

Modulating Energy Metabolism as a Therapeutic Approach for Alzheimer's Disease

$505,100
M Flint Beal · Winifred Masterson Burke Med Res Inst · P01 · FY2019 · AG

Modulating Energy Metabolism as a Therapeutic Approach for Alzheimer's Disease

$505,098
M Flint Beal · Winifred Masterson Burke Med Res Inst · P01 · FY2017 · AG